Glaukos Corporation vs Johnson & Johnson — Stock Comparison

GKOS
Glaukos Corporation
$140.22
▼ 2.40%
vs
JNJ
Johnson & Johnson
$227.19
▼ 1.16%
Q·Score Winner
Johnson & Johnson
JNJ7.1/10vs 5.8/10

Q·Score Breakdown

5.8
Neutral
Overall
7.1
Bullish
1.1
Quality
9.3
9.2
Health
6.5
7.4
Growth
5.1
4.2
Valuation
7.3
8.9
Sentiment
6.5
GKOS

Clean balance sheet with low leverage (0.2× debt-to-equity).

currently unprofitable (-34% margin).

JNJ

High-quality business with 26% return on equity and 22% profit margins.

earnings contracting 53% year-over-year.

Analyst Consensus

BUY
Target $151.08 (+7.7%)
12 analysts
BUY
Target $252.42 (+11.1%)
24 analysts

Fundamentals

GKOS
JNJ
Trailing P/E
26.3×
293.1×
Forward P/E
17.9×
-34.3%
Profit Margin
21.8%
78.1%
Gross Margin
68.0%
-26.4%
ROE
26.4%
41.2%
Revenue Growth
9.9%
Earnings Growth
-52.9%
0.78
Beta
0.33
Price / Book
$8.2B
Market Cap
$546.9B
$73 – $147
52-Week Range
$146 – $252

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →